Cognito Therapeutics, Inc.
Current Promotions
No video available
Get in Touch
About
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer's disease.
Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer's disease and expects to start pivotal studies in 2022. The company's technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.
Keywords
No keywords available
Amenities
No amenities listed yet
Upcoming Events
No upcoming events scheduled
Frequently Asked Questions
No FAQs available for this business.
Reviews
No reviews yet. Be the first to review!
Social Links
Photo Gallery
No photos available
Contact Information
Business Info
Location
Business Hours
Business hours not available
Own This Business?
Unclaimed
Take control of your business page to update information, respond to reviews, and more.
Claim This Business